Upperton’s GMP manufacturing facility passes MHRA inspection

Published: 24-Jul-2024

The GMP manufacturing facility of Upperton Pharma Solutions took 18 months to build, commission, validate and approve

You need to be a subscriber to read this article.
Click here to find out more.

Upperton Pharma Solutions, a contract development and manufacturing organisation has announced the successful completion of a Medicines and Healthcare products Regulatory Agency (MHRA) inspection at its newly commissioned 50,000 sqft development and GMP manufacturing facility in Nottingham, UK.

This milestone inspection, conducted by the UK Government’s regulatory authority, marks a significant achievement for Upperton Pharma Solutions following the completion of the build, commissioning, validation and approval of the facility in just 18 months.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cleanroom Technology.

Subscribe now Already a subscriber? Sign in here.

You may also like